Reports

Ideas That Generate Results

Cancer Generics Market Outlook 2017

Cancer Generics Market Outlook 2017

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jul, 2013| No. of Pages : 95

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1000.00
CD-ROM Mail Delivery
US$ 1100.00
Hard Copy Mail Delivery
US$ 1100.00
Electronic Access - Multi-User License
US$ 1400.00

List of Figures:

Figure 3-1: Global - Number of New Cancer Cases (Million), 2012 & 2020
Figure 4-1: Global - Cancer Drugs Market (Billion US$), 2012-2017
Figure 4-2: Global - Cancer Drugs Market by Drug Class (%), 2013
Figure 4-3: Global - Cancer Generics Market (Billion US$), 2012-2017
Figure 6-1: Global - Number of New Lung Cancer Cases (Million), 2009 & 2020
Figure 6-2: Global - New Lung Cancer Cases by Region (%), 2009
Figure 6-3: Global - Forecast for New Lung Cancer Cases by Region (%), 2020
Figure 6-4: Global - Number of New Breast Cancer Cases (Million), 2009 & 2020
Figure 6-5: Global - New Breast Cancer Cases by Region (%), 2009
Figure 6-6: Global - Forecast for New Breast Cancer Cases by Region (%), 2020
Figure 6-7: Global - Number of New Colorectal Cancer Cases (Million), 2009 & 2020
Figure 6-8: Global - New Colorectal Cancer Cases by Region (%), 2009
Figure 6-9: Global - Forecast for New Colorectal Cancer Cases by Region (%), 2020
Figure 6-10: Global - Number of New Stomach Cancer Cases (Million), 2009 & 2020
Figure 6-11: Global - New Stomach Cancer Cases by Region (%), 2009
Figure 6-12: Global - Forecast for New Stomach Cancer Cases by Region (%), 2020
Figure 6-13: Global - Number of New Prostate Cancer Cases (Million), 2009 & 2020
Figure 6-14: Global - New Prostate Cancer Cases by Region (%), 2009
Figure 6-15: Global - Forecast for New Prostate Cancer Cases by Region (%), 2020

List of Tables:

Table 3-1: Global - New Cases of Top Five Cancer’s by Geography (Number), 2009
Table 3-2: Global - Forecast for New Cases of Top Five Cancer’s by Geography (Number), 2020
Table 5-1: Oncology Drug Master Filings by Market Players
Table 6-1: Global - Key Lung Cancer Drugs and Patent Expiry Status
Table 6-2: Global - Key Breast Cancer Drugs and Patent Expiry Status
Table 6-3: Global - Key Colorectal Cancer Drugs and Patent Expiry Status
Table 6-4: Global - Key Stomach Cancer Drugs and Patent Expiry Status
Table 6-5: Global - Key Prostate Cancer Drugs and Patent Expiry Status
Table 7-1: List of Companies Dealing in Generic Arimidex (Anastrozole)
Table 7-2: Cost Comparison of Generics and Branded Arimidex (Anastrozole)
Table 7-3: List of Companies Dealing in Generic Casodex (Bicalutamide)
Table 7-4: Cost Comparison of Generics and Branded Casodex (Bicalutamide)
Table 7-5: Cost Comparison of Generics and Branded Aromasin (Exemestane)
Table 7-6: List of Companies Dealing in Generic Femara (Letrozole)
Table 7-7: Cost Comparison of Generics and Branded Femara (Letrozole)
Table 7-8: List of Companies Dealing in Generic Megace (Megestrol Acetate)
Table 7-9: Cost Comparison of Generics and Branded Megace (Megestrol Acetate)
Table 7-10: List of Companies Dealing in Generic Purinethol (Mercaptopurine)
Table 7-11 Cost Comparison of Generics and Branded Purinethol (Mercaptopurine)
Table 7-12 Cost Comparison of Generics and Branded Tarceva (Erlotinib)
Table 7-13: List of Companies Dealing in Generic Nolvadex (Tamoxifen Citrate)
Table 7-14 Cost Comparison of Generics and Branded Nolvadex (Tamoxifen Citrate)
Table 7-15: List of Companies Dealing in Generic Eulexin (Flutamide)
Table 7-16 Cost Comparison of Generics and Branded Eulexin (Flutamide)
Table 7-17: List of Companies Dealing in Generic Hydrea (Hydroxyurea)
Table 7-18: Cost Comparison of Generics and Branded Hydrea (Hydroxyurea)
Table 7-19: List of Companies Dealing in Generic Camptosar (Irinotecan Hydrochloride)
Table 7-20: Cost Comparison of Generics and Branded Camptosar (Irinotecan Hydrochloride)
Table 7-21: Cost Comparison of Generics and Branded Velcade (bortezomib)
Table 7-22: List of Companies Dealing in Generic Taxotere (Docetaxel)
Table 7-23 Cost Comparison of Generics and Branded Taxotere (Docetaxel)
Table 7-24: List of Companies Dealing in Generic Gemzar (Gemcitabine Hydrochloride)
Table 7-25: Cost Comparison of Generics and Branded Gemzar (Gemcitabine Hydrochloride)
Table 7-26: Cost Comparison of Generics and Branded Doxil (Doxorubicin Hydrochloride)
Table 7-27: List of Companies Dealing in Generic Ifex (Ifosfamide)
Table 8-1: Actavis - Key Cancer Generic Drugs
Table 8-2: Mylan - Key Cancer Generic Drugs
Table 8-3: Roxane - Key Cancer Generic Drugs
Table 8-4: Accord Healthcare - Key Cancer Generic Drugs
Table 8-5: Sun Pharmaceuticals - Key Cancer Generic Drugs
Table 8-6: Teva Pharmaceuticals - Key Cancer Generic Drugs
Table 8-7: Fresnius Kabi Pharmaceuticals - Key Cancer Generic Drugs

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.